Keck School of Medicine of USC

Event

USC Department of Ophthalmology Winter Symposium

presented by Keck School of Medicine of USC

2 others would like to attend.

Register Now

Notification icon Saturday, December 9, 2023 7:30 AM - 2 PM America/Los_Angeles

Location Icon 1975 Zonal Avenue, Los Angeles, CA 90033

Event info

OVERVIEW

This program will focus on providing the attendees an update on the latest aspects of ophthalmic best practices across the field, research updates regarding recently approved therapies for ophthalmic diseases, and research updates regarding pipeline therapies that may soon be available.

TARGET AUDIENCE

This course is intended for the comprehensive ophthalmologist, ophthalmic subspecialties, ophthalmology residents, fellows and optometrists. 

LEARNING OBJECTIVES

By the end of the course, participants will be able to:

  1. Identify and discuss the most recent techniques in the management of ocular conditions.
  2. Apply current research findings to better diagnose and manage patients with who present with a variety of ocular diseases in the general ophthalmology clinic.
  3. Examine the benefits of preventive medicine in the management of degenerative ocular disease.
  4. Appreciate the rationale for recent efforts used to attempt to mitigate the severity of or to regenerate the functions that is lost due to degenerative ocular disease.

ACCREDITATION

The Keck School of Medicine of the University of Southern California is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Keck School of Medicine of the University of Southern California designates this Live Activity activity for a maximum of 4.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 For more information please visit the official event page.

Faculty
  • Brian Song

    Course Director

2 others would like to attend.

Register Now


Comments 0
Login to view comments. Click here to Login